Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Country / region: Belgium Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20131
20171
20184
20191
20204
20215
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Active, not recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
BeiGene2
Incyte Corporation2
Jules Bordet Institute2
AstraZeneca1
Bayer1
Daiichi Sankyo1
Exelixis1
Federation Francophone de Cancerologie Digestive1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma20
Squamous Cell Carcinoma of Head and Neck5
Carcinoma, Non-Small-Cell Lung4
Endometrial Neoplasms4
Carcinoma, Hepatocellular3
Colorectal Neoplasms3
Esophageal Neoplasms3
Stomach Neoplasms3
Uterine Cervical Neoplasms3
Carcinoma, Merkel Cell2

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.